ACP review of performance measures for diabetes finds many inadequate
ACP critically reviewed current diabetes performance measures and found that only four of 14 commonly used indicators meet standards for quality and evidence-based care.
In a recent paper, “Quality Indicators for Diabetes in Adults: A Review of Performance Measures,” published in Annals of Internal Medicine, ACP critically reviewed current diabetes performance measures and found that only four of 14 commonly used indicators meet the College's stringent standards for quality and evidence-based care. In the paper, ACP emphasizes the need for methodologically sound and clinically meaningful measures of diabetes care that will lead to improvement in health outcomes for patients with diabetes.
ACP supports key measures of diabetes control, including kidney health evaluations, HbA1c control, eye exams, and the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and has proposed a measure aimed at increasing the use of newer pharmacological treatments. In 2024, ACP published “Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians” to provide clinical recommendations on the topic.